MBL77 OPTIONS

MBL77 Options

Not all individuals with CLL have to have therapy. Even with all the latest advances, the iwCLL still endorses watchful observation for people with asymptomatic illness.86 This recommendation relies on not less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Pema

read more